How to buy Biomerica stock (BMRA)

Biomerica is a medical devices business based in the US. Biomerica shares (BMRA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.28 – a decrease of 4.47% over the previous week. Biomerica employs 64 staff and has a trailing 12-month revenue of around $5.5 million.

Our top picks for where to buy Biomerica stock

Buy Biomerica stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Biomerica stock price (NASDAQ: BMRA)

Use our graph to track the performance of BMRA stocks over time.

Biomerica shares at a glance

• Key figures

Information last updated 2024-12-15.

Latest market close	$0.28
52-week range	$0.24 - $1.35
50-day moving average more info button	$0.33
200-day moving average more info button	$0.57
Wall St. target price	$13.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.37

Is it a good time to buy Biomerica stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biomerica price performance over time

Historical closes compared with the close of $0.272 from 2024-12-23

1 week (2024-12-18)	-6.53%
1 month (2024-11-25)	-15.26%
3 months (2024-09-25)	-20.77%
6 months (2024-06-25)	-35.98%

1 year (2023-12-22)	-77.61%
2 years (2022-12-23)	-92.67%
3 years (2021-12-23)	4.2
5 years (2019-12-24)	2.99

Biomerica financials

Revenue TTM	$5.5 million
Gross profit TTM	$446,000
Return on assets TTM	-38.54%
Return on equity TTM	-76.48%
Profit margin	-111.85%
Book value	$0.32
Market Capitalization more info button	$5.5 million

TTM: trailing 12 months

Biomerica share dividends

We're not expecting Biomerica to pay a dividend over the next 12 months.

Have Biomerica's shares ever split?

Biomerica's shares were split on a 1:2 basis on 13 November 1994 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biomerica shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Biomerica shares which in turn could have impacted Biomerica's share price.

Biomerica share price volatility

Over the last 12 months, Biomerica's shares have ranged in value from as little as $0.2415 up to $1.35. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biomerica's is -1.137. This would suggest that Biomerica's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biomerica has bucked the trend.

Biomerica overview

Biomerica, Inc. , a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria.

Frequently asked questions

null
What percentage of Biomerica is owned by insiders or institutions?
Currently 7.215% of Biomerica shares are held by insiders and 13.012% by institutions. How many people work for Biomerica?
Latest data suggests 64 work at Biomerica. When does the fiscal year end for Biomerica?
Biomerica's fiscal year ends in May. Where is Biomerica based?
Biomerica's address is: 17571 Von Karman Avenue, Irvine, CA, United States, 92614 What is Biomerica's ISIN number?
Biomerica's international securities identification number is: US09061H3075 What is Biomerica's CUSIP number?
Biomerica's Committee on Uniform Securities Identification Procedures number is: 09061H307